Von Willebrand disease (VWD) is a heterogeneous bleeding disorder caused by decrease or dysfunction of von Willebrand factor (VWF). A wide range of mutations in the VWF gene have been characterized; however, their cellular consequences are still poorly understood. Here we have used a recently developed approach to study the molecular and cellular basis of VWD. We isolated blood outgrowth endothelial cells (BOECs) from peripheral blood of 4 type 1 VWD and 4 type 2 VWD patients and 9 healthy controls. We confirmed the endothelial lineage of BOECs, then measured VWF messenger RNA (mRNA) and protein levels (before and after stimulation) and VWF multimers. Decreased mRNA levels were predictive of plasma VWF levels in type 1 VWD, confirming a defect in VWF synthesis. However, BOECs from this group of patients also showed defects in processing, storage, and/or secretion of VWF. Levels of VWF mRNA and protein were normal in BOECs from 3 type 2 VWD patients, supporting the dysfunctional VWF model. However, 1 type 2M patient showed decreased VWF synthesis and storage, indicating a complex cellular defect. These results demonstrate for the first time that isolation of endothelial cells from VWD patients provides novel insight into cellular mechanisms of the disease.
von willebrand disease endothelial cells, VWF gene mutations cellular mechanisms, blood outgrowth endothelial cells bleeding disorder, von willebrand factor synthesis storage, type 1 VWD molecular basis, type 2 VWD endothelial function, weibel palade bodies von willebrand, vascular biology bleeding disorders
Cite this article
Starke, R., Paschalaki, K., Dyer, C., Harrison-Lavoie, K., Cutler, J. A., McKinnon, T., Millar, C. M., Cutler, D., Laffan, M., & Randi, A. (2013). Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells. *Blood*, *121*(14), 2773-2784. https://doi.org/10.1182/blood-2012-06-435727
Starke R, Paschalaki K, Dyer C, Harrison-Lavoie K, Cutler JA, McKinnon T, et al. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells. Blood. 2013;121(14):2773-2784. doi:10.1182/blood-2012-06-435727
Starke, Richard, et al. "Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells." *Blood*, vol. 121, no. 14, 2013, pp. 2773-2784.
Naltrexone (NTX) is a non-selective antagonist of opioid receptors, primarily used in the therapy of opioid and alcohol dependence. Low-dose naltrexone (LDN) exhibits antagonistic action against the o...
Objective: Fetal Lower Urinary Tract Obstruction (LUTO) is associated with oligohydramnios and significant fetal morbidity, resulting in poor lung development and perinatal death. However, oligohydram...
Human embryogenesis is a complicated process by which a fertilized egg develops into an embryo. During the first eight weeks of development, the conceptus shifts from a single-celled zygote into a mul...
Modern urban human activities are largely restricted to the indoors, deprived of direct sunlight containing visible and near-infrared (NIR) wavelengths at high irradiance levels. Therapeutic exposure ...